Novo Nordisk A Revenue per Employee (NVO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Novo Nordisk A  (NYSE: NVO)
 

Novo Nordisk A's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 37.57% in the first quarter 2026, year on year to cumulative value of $50,962 million, Novo Nordisk A's revenue per employee grew on a trailing twelve months basis to $ 733,220. The productivity of Novo Nordisk A's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 11 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 311, from total ranking in previous quarter at 314. Novo Nordisk A has 69,505 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVO Revenue per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Revenue Change 37.57 % 0.7 % 11.78 % 18.95 % 15.86 %
Sales per Employee (TTM) $ 733,220 673,625 672,387 654,584 627,801
NVO's Total Ranking # 311 # 314 # # #
Seq. Revenue Change 22.55 % 5.42 % 0.48 % 5.98 % -10.3 %

NVO Company Profile >> Back to NVO Efficiency Comparisons >> Compare NVO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 12
Overall Market # 311

Revenue per Employee Statistics
High Average Low
$ 4,446,644 $ 1,323,821 $ 255,115
(Dec 31 2025)   (Dec 31 2018)



Financial Statements
Novo Nordisk A's Revenue MRQ $ 15,166 Millions Visit NVO's Income Statement
Novo Nordisk A's Revenues TTM $ 50,962 Millions Visit NVO's aggregate revenue growth
What are NVO's Sales? Visit NVO's Sales by Segment




Other Ratios
Novo Nordisk A's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NVO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NVO's Competitors
Revenue per Employee for NVO's Suppliers
Revenue per Employee for NVO's Customers

You may also want to know
NVO's Sales Growth Rates NVO's Pe Price to earnings ratio NVO's Receivables Turnover Ratio NVO's Stock Quote
NVO's Net Income Growth Rates NVO's Ps Price to Sales ratio NVO's Sales per Employee NVO's Asset Turnover Ratio
NVO's Net Margin NVO's Pb Price to Book ratio NVO's Financial Strength Ratios NVO's Dividend Payout Ratio
Date modified: 2026-09-30T13:42:16+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Puma Biotechnology Inc   1,269,150.84 $ 227.178  Million 179 
Madrigal Pharmaceuticals Inc   1,237,693.99 $ 1,132.490  Million 915 
Theravance Biopharma inc   1,219,722.22 $ 109.775  Million 90 
Akebia Therapeutics Inc   1,197,958.76 $ 232.404  Million 194 
Supernus Pharmaceuticals inc   1,191,461.66 $ 776.833  Million 652 
Arcutis Biotherapeutics Inc   1,174,079.10 $ 415.624  Million 354 
Heron Therapeutics Inc   1,173,312.50 $ 150.184  Million 128 
Cue Biopharma Inc   1,128,655.17 $ 32.731  Million 29 
Journey Medical Corp  1,115,172.41 $ 64.680  Million 58 
Abbvie Inc   1,102,087.72 $ 62,819.000  Million 57,000 
Travere Therapeutics Inc   1,078,863.18 $ 536.195  Million 497 
Corcept Therapeutics Inc  1,053,556.16 $ 769.096  Million 730 
Biomarin Pharmaceutical Inc  1,006,617.82 $ 3,242.316  Million 3,221 
Scilex Holding Company  995,941.18 $ 33.862  Million 34 
Coya Therapeutics Inc   992,377.00 $ 7.939  Million 8 
Sanara Medtech Inc   989,563.23 $ 106.873  Million 108 
Assembly Biosciences Inc   973,931.51 $ 71.097  Million 73 
Hims and Hers Health Inc   970,301.39 $ 2,369.476  Million 2,442 
Regeneron Pharmaceuticals Inc   968,176.51 $ 14,919.600  Million 15,410 
Ani Pharmaceuticals Inc  952,274.23 $ 923.706  Million 970 
Evolus Inc   905,236.53 $ 302.349  Million 334 
Pacira Biosciences inc   886,446.32 $ 734.864  Million 829 
Keenova Therapeutics Plc  883,125.00 $ 1,413.000  Million 1,600 
Nektar Therapeutics  883,063.49 $ 55.633  Million 63 
Merck and Co Inc   876,906.67 $ 65,768.000  Million 75,000 
Arrowhead Pharmaceuticals Inc   874,836.85 $ 622.009  Million 711 
Ardelyx inc   874,599.18 $ 427.679  Million 489 
Lifevantage Corp  868,242.15 $ 193.618  Million 223 
Prothena Corporation Public Limited Company  864,776.12 $ 57.940  Million 67 
Alphatec Holdings Inc   861,301.20 $ 786.368  Million 913 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.